ACCELERATING THE DEVELOPMENT OF INHALED CASEIN KINASE 1 INHIBITORS FOR SEVERE ASTHMA AND OTHER CHRONIC RESPIRATORY DISEASES

| Funding period: 2018 - 2020

Completed

University of Melbourne Researchers